Quarterly report pursuant to Section 13 or 15(d)

Treasury Bills

v3.2.0.727
Treasury Bills
6 Months Ended
Jun. 30, 2015
Equity [Abstract]  
Treasury Bills

NOTE – 4 TREASURY BILLS

The fair values of Milestone marketable securities are determined in accordance with GAAP, with fair value being defined as the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. As such, fair value is a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset or liability. As a basis for considering such assumptions, Milestone Scientific utilizes the three-tier value hierarchy, as prescribed by GAAP, which prioritizes the inputs used in measuring fair value, as follows:

 

    Level 1 - inputs to the valuation methodology are quoted prices (unadjusted) for identical assets or liabilities in active markets.

 

    Level 2 - inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, and inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the financial instrument.

 

    Level 3 - inputs to the valuation methodology are unobservable and significant to the fair value measurement.

Milestone Scientific invests excess cash in Treasury Bills with varying maturities, which are classified as available-for-sale securities and are re-measured to fair value on a recurring basis and are valued using Level 1 inputs, which are quoted prices (unadjusted) for identical assets in active markets:

 

June 30, 2015

   Cost      Fair Value      Unrealized Gain (Loss)  

Available for sale:

        

Treasury Bills

   $ 5,551,383       $ 5,550,283       $ 1,100